blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1443971

EP1443971 - METHOD OF USING 18080, A HUMAN SERINE CARBOXYPEPTIDASE FAMILY MEMBER [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.09.2007
Database last updated on 09.09.2024
Most recent event   Tooltip07.09.2007Application deemed to be withdrawnpublished on 10.10.2007  [2007/41]
Applicant(s)For all designated states
MILLENNIUM PHARMACEUTICALS, INC.
75 Sidney Street Cambridge
Massachusetts 02139 / US
[N/P]
Former [2004/33]For all designated states
Millennium Pharmaceuticals, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
Inventor(s)01 / CARROLL, Joseph, M.
113 Sciarappa Street
Cambridge, MA 02141 / US
 [2004/33]
Representative(s)Hall, Robert Leonard
Harrison Goddard Foote Fountain Precinct Balm Green Sheffield
S1 2JA / GB
[N/P]
Former [2004/33]Hall, Robert Leonard
Harrison Goddard Foote, Fountain Precinct Balm Green
Sheffield S1 2JA / GB
Application number, filing date02799190.013.11.2002
[2004/33]
WO2002US36473
Priority number, dateUS20010338587P13.11.2001         Original published format: US 338587 P
[2004/33]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03041652
Date:22.05.2003
Language:EN
[2003/21]
Type: A2 Application without search report 
No.:EP1443971
Date:11.08.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 22.05.2003 takes the place of the publication of the European patent application.
[2004/33]
Search report(s)International search report - published on:US14.08.2003
(Supplementary) European search report - dispatched on:EP29.12.2006
ClassificationIPC:A61K48/00, A61K39/395, A61K38/00, A61K38/48, A61P7/00, A61P7/06, A61P35/00
[2006/45]
CPC:
A61K39/00 (EP,US); A61K38/16 (EP,US); A61K38/4813 (EP,US);
A61P35/00 (EP); A61P7/00 (EP); A61P7/06 (EP);
A61K2039/53 (EP,US) (-)
C-Set:
A61K38/16, A61K2300/00 (EP,US)
Former IPC [2004/33]A61K48/00, A61K39/395, A61K38/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/33]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERFAHREN ZUR VERWENDUNG VON 18080, EINEM MITGLIED DER HUMANEN SERINCARBOXYPEPTIDASE-FAMILIE[2004/33]
English:METHOD OF USING 18080, A HUMAN SERINE CARBOXYPEPTIDASE FAMILY MEMBER[2004/33]
French:METHODE D'UTILISATION DE 18080, ELEMENT DE LA FAMILLE DE LA SERINE CARBOXYPEPTIDASE HUMAINE[2004/33]
Entry into regional phase15.03.2004National basic fee paid 
15.03.2004Search fee paid 
15.03.2004Designation fee(s) paid 
15.03.2004Examination fee paid 
Examination procedure15.03.2004Amendment by applicant (claims and/or description)
15.03.2004Examination requested  [2004/33]
26.03.2007Application deemed to be withdrawn, date of legal effect  [2007/41]
22.05.2007Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2007/41]
Fees paidRenewal fee
22.11.2004Renewal fee patent year 03
29.11.2005Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.11.200605   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9914234  (GENENTECH INC [US], et al);
 [A]WO0015792  (GENENTECH INC [US], et al);
 [A]WO0119987  (GENENTECH INC [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.